Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics
出版年份 2014 全文链接
标题
Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 106, Issue 5, Pages dju044-dju044
出版商
Oxford University Press (OUP)
发表日期
2014-03-13
DOI
10.1093/jnci/dju044
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Challenges in Interpreting the Evidence for Genetic Predictors of Ototoxicity
- (2013) M J Ratain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer
- (2013) J J Yang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
- (2013) K Pussegoda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genome-Wide Variation of Cytosine Modifications Between European and African Populations and the Implications for Complex Traits
- (2013) Erika L. Moen et al. GENETICS
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
- (2013) Melissa M. Hudson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and use of active clinical decision support for preemptive pharmacogenomics
- (2013) Gillian C Bell et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Turning of COGS moves forward findings for hormonally mediated cancers
- (2013) Lori C Sakoda et al. NATURE GENETICS
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
- (2013) Lois B. Travis et al. Nature Reviews Clinical Oncology
- Understanding platinum-induced ototoxicity
- (2013) Thorsten Langer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulatory Polymorphisms in -Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy
- (2012) L. J. Leandro-Garcia et al. CLINICAL CANCER RESEARCH
- A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101
- (2012) R. M. Baldwin et al. CLINICAL CANCER RESEARCH
- Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy
- (2012) H. E. Wheeler et al. CLINICAL CANCER RESEARCH
- Clinical Translation of Cell-Based Pharmacogenomic Discovery
- (2012) N J Cox et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics
- (2012) P H O'Donnell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Link between the Metabolic Syndrome and Cancer
- (2012) Sandra Braun et al. International Journal of Biological Sciences
- Leveraging Epidemiology and Clinical Studies of Cancer Outcomes: Recommendations and Opportunities for Translational Research
- (2012) Joanne W. Elena et al. JNCI-Journal of the National Cancer Institute
- Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy
- (2012) Lois B. Travis et al. JNCI-Journal of the National Cancer Institute
- Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
- (2012) Xiaojing Xu et al. LUNG CANCER
- Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
- (2012) W. Grisold et al. NEURO-ONCOLOGY
- Relating human genetic variation to variation in drug responses
- (2012) Ashraf G. Madian et al. TRENDS IN GENETICS
- Estimating Missing Heritability for Disease from Genome-wide Association Studies
- (2011) Sang Hong Lee et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
- (2011) S. Bhatia CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
- (2011) Andreas A. Argyriou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer Risk Among Patients With Myotonic Muscular Dystrophy
- (2011) Shahinaz M. Gadalla et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer
- (2011) Raoul C. Reulen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer
- (2011) Mette Sprauten et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
- (2011) Guido Cavaletti et al. LANCET ONCOLOGY
- Alcohol-related peripheral neuropathy: Nutritional, toxic, or both?
- (2011) Michelle Mellion et al. MUSCLE & NERVE
- Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation
- (2011) Heather E Wheeler et al. PHARMACOGENOMICS
- Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
- (2011) H E Wheeler et al. PHARMACOGENOMICS JOURNAL
- Population differences in microRNA expression and biological implications
- (2011) R. Stephanie Huang et al. RNA Biology
- Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
- (2010) Ana Bosch et al. CANCER TREATMENT REVIEWS
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
- (2010) Guido Cavaletti et al. EUROPEAN JOURNAL OF CANCER
- Presbycusis phenotypes form a heterogeneous continuum when ordered by degree and configuration of hearing loss
- (2010) Paul D. Allen et al. HEARING RESEARCH
- Testicular Cancer Survivorship: Research Strategies and Recommendations
- (2010) L. B. Travis et al. JNCI-Journal of the National Cancer Institute
- Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
- (2010) Annemiek Broyl et al. LANCET ONCOLOGY
- The metabolic syndrome in cancer survivors
- (2010) Esther C de Haas et al. LANCET ONCOLOGY
- Missing heritability and strategies for finding the underlying causes of complex disease
- (2010) Evan E. Eichler et al. NATURE REVIEWS GENETICS
- Auditory Late Effects of Childhood Cancer Therapy: A Report From the Children's Oncology Group
- (2010) S. Grewal et al. PEDIATRICS
- Years of Potential Life Lost and Productivity Losses From Male Urogenital Cancer Deaths—United States, 2004
- (2010) Chunyu Li et al. UROLOGY
- Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
- (2009) Peter D. Inskip et al. JOURNAL OF CLINICAL ONCOLOGY
- The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research
- (2009) Leslie L. Robison et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors
- (2009) M. Brydoy et al. JNCI-Journal of the National Cancer Institute
- Finding the missing heritability of complex diseases
- (2009) Teri A. Manolio et al. NATURE
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
- (2009) A V Khrunin et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenomic Discovery Using Cell-Based Models
- (2009) M. Welsh et al. PHARMACOLOGICAL REVIEWS
- Secondary Malignancies Across the Age Spectrum
- (2009) Andrea K. Ng et al. SEMINARS IN RADIATION ONCOLOGY
- Genetic Architecture of Transcript-Level Variation in Humans
- (2008) Shiwei Duan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Platinum-based chemotherapy in triple-negative breast cancer
- (2008) B. Sirohi et al. ANNALS OF ONCOLOGY
- Cardiovascular risk in long-term survivors of testicular cancer
- (2008) David J. Vaughn et al. CANCER
- Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy
- (2008) Ji Eun Uhm et al. INTERNATIONAL JOURNAL OF CANCER
- Short Interfering RNA against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-Induced Hearing Loss in the Rat
- (2008) D. Mukherjea et al. JOURNAL OF NEUROSCIENCE
- Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis
- (2008) Sunita J. Shukla et al. Pharmacogenetics and Genomics
- Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions
- (2008) M R Nelson et al. PHARMACOGENOMICS JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started